DYNAVAX TECHNOLOGIES CORP revenue breakdown overview

DYNAVAX TECHNOLOGIES CORP revenue for the last year amounted to 210.45 M EUR, the most of which — 210.45 M EUR — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 675.25 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought DYNAVAX TECHNOLOGIES CORP 209.24 M EUR, and the year before that — 124.99 M EUR.